AUSTIN, Texas--(BUSINESS WIRE)--atsec AB Stockholm, Sweden is thrilled to announce: We are the first IEEE Authorized Testing Facility! We've officially been approved as an IEEE Authorized Testing ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

MT. LAUREL, N.J.--(BUSINESS WIRE)--InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target ...

MT. LAUREL, N.J.--(BUSINESS WIRE)-- InTest Corporation (INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which ...

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...

As ‍ ‌‍ ‍‌ ‍ ‌‍ ‍‌ data-driven innovation profoundly changes every industry, the healthcare sector is also affected. Digital twins – virtual copies of physical devices – are essentially changing the ...

Some of the most challenging leakage-current-testing requirements are those for patient-monitoring devices—both invasive and noninvasive. Such testing can be time-consuming and expensive, so it is ...

InTest Corporation (NYSE American: INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ( ...

BARBERTON, Ohio—Best kept secrets don't really ever stay secrets. Because best kept secrets—by their very nature—are defined by the good stuff: the excellence, experience, depth and quality that lies ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed a record number of device trial approvals in the UK in 2025. During the year, the MHRA approved 17% more clinical ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services. NEW YORK, NY, UNITED STATES, January 26, 2026 ...

TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...